CN Patent

CN102099026B — 含美西特田的治疗组合物

Assigned to Actelion Pharmaceuticals Ltd · Expires 2012-08-29 · 14y expired

What this patent protects

本发明关于一种产品，其包含下式(I)的化合物 或该化合物的医药可接受盐，与至少一种具有前列腺环素受体(IP)激动剂性质的化合物或其医药可接受盐组合。

USPTO Abstract

本发明关于一种产品，其包含下式(I)的化合物 或该化合物的医药可接受盐，与至少一种具有前列腺环素受体(IP)激动剂性质的化合物或其医药可接受盐组合。

Drugs covered by this patent

Patent Metadata

Patent number
CN102099026B
Jurisdiction
CN
Classification
—
Expires
2012-08-29
Drug substance claim
No
Drug product claim
No
Assignee
Actelion Pharmaceuticals Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.